Patrick Petitpretz

Summary

Affiliation: Centre Hospitalier de Versailles
Country: France

Publications

  1. ncbi Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval
    Patrick Petitpretz
    Hopital Andre Mignot, Le Chesnay, France
    Int J Antimicrob Agents 30:52-9. 2007

Detail Information

Publications1

  1. ncbi Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval
    Patrick Petitpretz
    Hopital Andre Mignot, Le Chesnay, France
    Int J Antimicrob Agents 30:52-9. 2007
    ..In addition to demonstrating the non-inferiority of levofloxacin compared with cefuroxime in AECOB, the data from this study raise the question of whether EFI is a useful discriminative endpoint for comparing antimicrobial therapies...